Active, not recruitingPhase 3NCT03876262
Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis
Studying Onchocerciasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medicines Development for Global Health
- Principal Investigator
- Tony Ukety, MD, DO, MPHCentre de Recherche en Maladies Tropicales de l'Ituri
- Intervention
- Moxidectin(drug)
- Enrollment
- 323 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Centre de Recherche pour les Maladies Tropicales Negligees, Rethy, Ituri, Democratic Republic of the Congo
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03876262 on ClinicalTrials.govOther trials for Onchocerciasis
Additional recruiting or active studies for the same condition.